Posted on

Arteriocyte, Inc. is a medical device company committed to novel medical products to improve surgical outcomes, including cardiac, orthopedic and vascular surgeries. They produce the Magellan Autologous Platelet Separator System – an automated platelet separator and Platelet Rich Plasma (PRP) production system. Arteriocyte is also a clinical stage biotechnology researcher currently developing proprietary stem cell and tissue engineering based therapies.